文献速递头颈与中枢神经肿瘤

头颈癌个体化放疗的未来

The future of personalised radiotherapy for head and neck cancer.
PubMed 文献 · Lancet Oncol · 2017-04-26

本文为系列综述,探讨利用基因组学、影像组学和数学建模等精准医学工具,识别头颈癌患者间表型和基因型差异,推动放疗从经验性剂量与分次模式转向基于证据的个体化与生物学适应放疗,作者认为这些方法有望改善疗效并减少毒性。

要点

  • 头颈癌传统放疗按TNM分期给予相同方案,作者认为存在超越技术与解剖精准的改进空间。
  • 基因组学、影像组学和数学建模等工具可揭示患者与肿瘤间的表型及基因型差异。
  • 作者提出从经验性剂量与分次时代转向证据驱动的个体化及生物学适应放疗。

核心结论

  • 作者认为利用精准医学工具推动个体化与生物学适应放疗,有望改善头颈癌患者疗效并减少毒性。

研究设计与样本

  • 本文为系列综述,探讨头颈癌个体化放疗的新思路与精准医学工具的应用前景。

主要发现

  • 作者指出传统放疗为按分期依赖的策略,即同一TNM分期的所有患者接受相同治疗。
  • 作者认为基因组学、影像组学和数学建模等工具有助于理解患者及其肿瘤间的表型和基因型差异。
  • 作者提出治疗模式应从经验性剂量与分次转向以证据为导向的个体化及生物学适应放疗。

临床怎么用

  • 原文未据此给出具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radiotherapy has long been the mainstay of treatment for patients with head and neck cancer and has traditionally involved a stage-dependent strategy whereby all patients with the same TNM stage receive the same therapy. We believe there is a substantial opportunity to improve radiotherapy delivery beyond just technological and anatomical precision. In this Series paper, we explore several new ideas that could improve understanding of the phenotypic and genotypic differences that exist between patients and their tumours. We discuss how exploiting these differences and taking advantage of precision medicine tools-such as genomics, radiomics, and mathematical modelling-could open new doors to personalised radiotherapy adaptation and treatment. We propose a new treatment shift that moves away from an era of empirical dosing and fractionation to an era focused on the development of evidence to guide personalisation and biological adaptation of radiotherapy. We believe these approaches offer the potential to improve outcomes and reduce toxicity.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Caudell JJ, Torres-Roca JF, Gillies RJ, et al. The future of personalised radiotherapy for head and neck cancer. Lancet Oncol. 2017. PMID: 28456586. doi:10.1016/S1470-2045(17)30252-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。